SAN DIEGO, Oct. 25 – Incyte Genomics on Thursday announced it will jettison its custom genomics program and layoff roughly 400 employees as it restructures its business.

The discontinuation of the custom genomics product lines will lead Incyte to close its facilities in Fremont, Calif., and St. Louis, the company said. Details of the schedule for the shutdown were not disclosed.

The company also announced it was considering ending its internal therapeutic SNP discovery program, which is conducted in Cambridge, England, by the end of the year. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.